Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	6.43	50.29	47.25
Graham Fair Price	13.27	19.99	17.65
PEG	300.82	2.56	0.64
Price/Book	13.55	2.53	2.23
Price/Cash Flow	504.98	275.53	45.54
Prices/Earnings	-9.70	32.69	36.20
Price/Sales	16.10	13.25	11.41
Price/FCF	504.98	275.53	45.54
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	2.57	0.38	0.37
Operating Margin	7.92	0.20	0.18
ROA	26.80	< 0.005	< 0.005
ROE	0.02	0.02	25.75
ROIC	0.02	0.02	13.90
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.07	0.04	90.79
Dividends QOQ	< 0.005	< 0.005	-1117.30
EBIT QOQ	0.35	0.07	-80.15
EPS QOQ	0.57	0.13	-77.47
FCF QOQ	3.70	-0.81	-78.13
Revenue QOQ	0.05	< 0.005	-81.41
Naive Interpretation	member

03 - Financial Growth · Bad

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	25.15	23.76	-5.56
Days Sales Outstanding (DSO)	62.07	81.36	31.08
Inventory Turnover	3.58	3.79	5.89
Debt/Capitalization	0.38	0.36	-6.10
Quick Ratio	1.11	1.06	-4.16
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	29.97	30.28	1.01
Cash	4.08	3.26	-20.04
Capex	-0.61	-0.40	34.66
Free Cash Flow	1.47	0.28	-81.04
Revenue	5.86	5.79	-1.21
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.35	1.29	-4.72
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	11.66	10.73	-7.98
Naive Interpretation	Member

06 - Financial Health · Weak

Rating